home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

AngioDynamics, Inc. - Common Stock (NQ:ANGO)

12.89 +0.08 (+0.62%)

Streaming Delayed Price Updated: 12:24 PM EDT, Jul 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AngioDynamics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement ↗

April 02, 2024

AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses and marking a significant milestone for the company.

Via Benzinga

Topics Intellectual Property

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.

April 01, 2024

From AngioDynamics, Inc.

Via Business Wire

AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024

March 19, 2024

From AngioDynamics, Inc.

Via Business Wire

AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference

March 06, 2024

From AngioDynamics, Inc.

Via Business Wire

Earnings Preview For AngioDynamics ↗

January 04, 2024

Via Benzinga

What 4 Analyst Ratings Have To Say About AngioDynamics ↗

October 05, 2023

Via Benzinga

Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound ↗

March 04, 2024

While red ink signals danger, for these oversold stocks ready for rebound, they could imply upside opportunities.

Via InvestorPlace

AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million

February 15, 2024

From AngioDynamics, Inc.

Via Business Wire

AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why ↗

February 11, 2024

The medical device maker's shares have seen an increase of 1.49% over the last month, not keeping up with the Medical sector's gain of 2.05% and the S&P 500's gain of 5.07%.

Via Talk Markets

Topics Stocks

AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease

January 23, 2024

From AngioDynamics, Inc.

Via Business Wire

Why Angiodynamics Stock Sank Today ↗

October 04, 2023

The company didn't get investors excited about its latest set of quarterly figures.

Via The Motley Fool

Preview: AngioDynamics's Earnings ↗

October 03, 2023

Via Benzinga

Raymond James Maintains Outperform Rating for AngioDynamics: Here's What You Need To Know ↗

January 09, 2024

Via Benzinga

Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday ↗

January 08, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Why AngioDynamics Stock Got Destroyed Today ↗

January 05, 2024

The medical technology company is a perennial underperformer, but its latest quarterly report was worse than expected.

Via The Motley Fool

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 05, 2024

Shares of Applied Therapeutics, Inc.

Via Benzinga

ANGO Stock Earnings: AngioDynamics Beats EPS, Misses Revenue for Q2 2024 ↗

January 05, 2024

ANGO stock results show that AngioDynamics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

Why Is Medical Devices-Focused AngioDynamics Stock Trading Lower Today? ↗

January 05, 2024

AngioDynamics Inc (NASDAQ: ANGO) has reported a second-quarter (Q2) FY24 adjusted EPS loss of $(0.05), compared to the consensus of $(0.07) and EPS income of

Via Benzinga

US Stocks Poised To Extend New Year Slump As Focus Shifts To December Jobs Data: Analyst Sees S&P Testing 4,800 On This Condition ↗

January 05, 2024

Important metrics to track include the flow of individuals entering the labor force and the ratio of part-time workers to full-timers.

Via Benzinga

Topics Stocks

AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance

January 05, 2024

From AngioDynamics, Inc.

Via Business Wire

Investor Sentiment Edges Lower Ahead Of Jobs Report; Nasdaq Tumbles For 5th Consecutive Day ↗

January 05, 2024

The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, with the index moving to the "Greed" zone on Thursday. U.S. stocks closed mixed on Thursday, with the Nasdaq...

Via Benzinga

Topics Stocks

Costco Wholesale, Constellation Brands And 3 Stocks To Watch Heading Into Friday ↗

January 05, 2024

With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Earnings Scheduled For January 5, 2024 ↗

January 05, 2024

Companies Reporting Before The Bell • Constellation Brands (NYSE:STZ) is estimated to report quarterly earnings at $3.00 per share on revenue of $2.54 billion.

Via Benzinga

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

December 21, 2023

From AngioDynamics, Inc.

Via Business Wire

AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024

December 07, 2023

From AngioDynamics, Inc.

Via Business Wire

AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

December 07, 2023

From AngioDynamics, Inc.

Via Business Wire

Constellation Brands To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Friday ↗

October 06, 2023

HSBC raised the price target for Constellation Brands, Inc. (NYSE: STZ) from $280 to $290. HSBC analyst Carlos Laboy maintained a Buy rating. Constellation shares fell 3.2% to close at $241.33 on...

Via Benzinga

Medical Devices Player AngioDynamics Exceeds Q1 Expectations, Sticks To Annual Guidance ↗

October 04, 2023

AngioDynamics Inc (NASDAQ: ANGO) has reported a Q1 FY24 adjusted EPS loss of $(0.12), beating the consensus of $(0.13) but higher than $(0.06) reported a year ago.

Via Benzinga

S&P 500, Nasdaq Face Uphill Battle As Bond Yields Rise; Analyst Pins Hope On Key Jobs Data This Week ↗

October 04, 2023

Stock futures point to a nervous start yet again on Wednesday as the 10-year T-note set a fresh 16-year high.

Via Benzinga

Topics Stocks

AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance

October 04, 2023

From AngioDynamics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com